These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9141214)

  • 1. Subgroup specific protection of mice from respiratory syncytial virus infection with peptides encompassing the amino acid region 174-187 from the G glycoprotein: the role of cysteinyl residues in protection.
    Simard C; Nadon F; Séguin C; Thien NN; Binz H; Basso J; Laliberté JF; Trudel M
    Vaccine; 1997 Mar; 15(4):423-32. PubMed ID: 9141214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein.
    Plotnicky-Gilquin H; Goetsch L; Huss T; Champion T; Beck A; Haeuw JF; Nguyen TN; Bonnefoy JY; Corvaïa N; Power UF
    J Virol; 1999 Jul; 73(7):5637-45. PubMed ID: 10364313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of linear epitopes recognised by the primary human antibody response to a variable region of the attachment (G) protein of respiratory syncytial virus.
    Cane PA
    J Med Virol; 1997 Apr; 51(4):297-304. PubMed ID: 9093944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that the amino acid region 124-203 of glycoprotein G from the respiratory syncytial virus (RSV) constitutes a major part of the polypeptide domain that is involved in the protection against RSV infection.
    Simard C; Nadon F; Séguin C; Trudel M
    Antiviral Res; 1995 Dec; 28(4):303-15. PubMed ID: 8669890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment G protein.
    Bembridge GP; Garcia-Beato R; López JA; Melero JA; Taylor G
    J Immunol; 1998 Sep; 161(5):2473-80. PubMed ID: 9725246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4(+) T-cell-mediated antiviral protection of the upper respiratory tract in BALB/c mice following parenteral immunization with a recombinant respiratory syncytial virus G protein fragment.
    Plotnicky-Gilquin H; Robert A; Chevalet L; Haeuw JF; Beck A; Bonnefoy JY; Brandt C; Siegrist CA; Nguyen TN; Power UF
    J Virol; 2000 Apr; 74(8):3455-63. PubMed ID: 10729118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type-specific serologic diagnosis of respiratory syncytial virus infection, based on a synthetic peptide of the attachment protein G.
    Langedijk JP; Middel WG; Schaaper WM; Meloen RH; Kramps JA; Brandenburg AH; van Oirschot JT
    J Immunol Methods; 1996 Jun; 193(2):157-66. PubMed ID: 8699029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of subgroup-specific peptides of the G protein of respiratory syncytial virus for characterization of the immune response.
    Akerlind-Stopner B; Utter G; Norrby E; Mufson MA
    J Med Virol; 1995 Oct; 47(2):120-5. PubMed ID: 8830114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective immune responses induced by the immunization of mice with a recombinant bacteriophage displaying an epitope of the human respiratory syncytial virus.
    Bastien N; Trudel M; Simard C
    Virology; 1997 Jul; 234(1):118-22. PubMed ID: 9234952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with a peptide derived from the G glycoprotein of bovine respiratory syncytial virus (BRSV) reduces the incidence of BRSV-associated pneumonia in the natural host.
    Bastien N; Taylor G; Thomas LH; Wyld SG; Simard C; Trudel M
    Vaccine; 1997; 15(12-13):1385-90. PubMed ID: 9302749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment.
    Power UF; Plotnicky-Gilquin H; Huss T; Robert A; Trudel M; Ståhl S; Uhlén M; Nguyen TN; Binz H
    Virology; 1997 Apr; 230(2):155-66. PubMed ID: 9143271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone.
    Schmidt AC; Wenzke DR; McAuliffe JM; St Claire M; Elkins WR; Murphy BR; Collins PL
    J Virol; 2002 Feb; 76(3):1089-99. PubMed ID: 11773385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide mimics of a conformationally constrained protective epitopes of respiratory syncytial virus fusion protein.
    Chargelegue D; Obeid OE; Shaw DM; Denbury AN; Hobby P; Hsu SC; Steward MW
    Immunol Lett; 1997 Jun; 57(1-3):15-7. PubMed ID: 9232419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
    Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
    Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A subgroup-specific antigenic site in the G protein of respiratory syncytial virus forms a disulfide-bonded loop.
    Akerlind-Stopner B; Utter G; Mufson MA; Orvell C; Lerner RA; Norrby E
    J Virol; 1990 Oct; 64(10):5143-8. PubMed ID: 1697913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus.
    Kulkarni AB; Collins PL; Bacik I; Yewdell JW; Bennink JR; Crowe JE; Murphy BR
    J Virol; 1995 Feb; 69(2):1261-4. PubMed ID: 7815502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single amino acid substitution in a recombinant G protein vaccine drastically curtails protective immunity against respiratory syncytial virus (RSV).
    Huang Y; Anderson R
    Vaccine; 2003 Jun; 21(19-20):2500-5. PubMed ID: 12744884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunodominant T-cell epitope on the F protein of respiratory syncytial virus recognized by human lymphocytes.
    Levely ME; Bannow CA; Smith CW; Nicholas JA
    J Virol; 1991 Jul; 65(7):3789-96. PubMed ID: 1710289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection.
    Srikiatkhachorn A; Braciale TJ
    J Exp Med; 1997 Aug; 186(3):421-32. PubMed ID: 9236194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping an antibody-binding site and a T-cell-stimulating site on the 1A protein of respiratory syncytial virus.
    Nicholas JA; Mitchell MA; Levely ME; Rubino KL; Kinner JH; Harn NK; Smith CW
    J Virol; 1988 Dec; 62(12):4465-73. PubMed ID: 2460636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.